BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25339434)

  • 1. Current concept and epidemiology of systemic vasculitides.
    Katsuyama T; Sada KE; Makino H
    Allergol Int; 2014 Dec; 63(4):505-13. PubMed ID: 25339434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?
    Watts RA
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():21-27. PubMed ID: 29707909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the consensus methodology algorithm for the classification of systemic necrotizing vasculitis in Indian patients.
    Sharma A; Mittal T; Rajan R; Rathi M; Nada R; Minz RW; Joshi K; Sakhuja V; Singh S
    Int J Rheum Dis; 2014 May; 17(4):408-11. PubMed ID: 24188067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the epidemiology, risk factors, and outcomes of systemic vasculitides.
    Berti A; Dejaco C
    Best Pract Res Clin Rheumatol; 2018 Apr; 32(2):271-294. PubMed ID: 30527432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology.
    Kamali S; Artim-Esen B; Erer B; Ozdener L; Gul A; Ocal L; Aral O; Inanc M
    Clin Rheumatol; 2012 Feb; 31(2):325-8. PubMed ID: 21814755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and classification of microscopic polyangiitis.
    Kallenberg CG
    J Autoimmun; 2014; 48-49():90-3. PubMed ID: 24461388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New features of disease after diagnosis in 6 forms of systemic vasculitis.
    Grayson PC; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Monach PA; Seo P; Specks U; Ytterberg SR; Merkel PA;
    J Rheumatol; 2013 Nov; 40(11):1905-12. PubMed ID: 23908447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary involvement in primary systemic vasculitides.
    Makhzoum JP; Grayson PC; Ponte C; Robson J; Suppiah R; Watts RA; Luqmani R; Merkel PA; Pagnoux C;
    Rheumatology (Oxford); 2021 Dec; 61(1):319-330. PubMed ID: 33788906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction, epidemiology and classification of vasculitis.
    Watts RA; Robson J
    Best Pract Res Clin Rheumatol; 2018 Feb; 32(1):3-20. PubMed ID: 30526896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
    Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.
    Radice A; Bianchi L; Sinico RA
    Autoimmun Rev; 2013 Feb; 12(4):487-95. PubMed ID: 22921790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advance in vasculitis syndrome].
    Kobayashi S; Hashimoto H
    Nihon Rinsho; 1999 Feb; 57(2):388-92. PubMed ID: 10078011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of ANCA-associated vasculitis.
    Khan I; Watts RA
    Curr Rheumatol Rep; 2013 Dec; 15(12):383. PubMed ID: 24203096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital-based Retrospective Study.
    Nesher G; Ben-Chetrit E; Mazal B; Breuer GS
    J Rheumatol; 2016 Jun; 43(6):1072-7. PubMed ID: 27084915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different epidemiologic profiles of systemic vasculitis between Brazil and Peru-preliminary results in two referral centers from both countries.
    de Souza AWS; Zarur EB; Pimentel-Quiroz VR; Sanchez-Torres A; Ugarte-Gil MF; Sato EI
    Clin Rheumatol; 2022 Mar; 41(3):635-639. PubMed ID: 35083562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and clinical features of systemic vasculitis.
    Scott DGI; Watts RA
    Clin Exp Nephrol; 2013 Oct; 17(5):607-610. PubMed ID: 23843034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of Remission in antineutrophil cytoplasm antibody-associated vasculitides.
    Guillevin L; Terrier B
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():100-104. PubMed ID: 29673090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.
    Herlyn K; Buckert F; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and epidemiology of the vasculitides.
    Watts RA; Scott DG
    Baillieres Clin Rheumatol; 1997 May; 11(2):191-217. PubMed ID: 9220075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic vasculitides classification].
    Guillevin L; Terrier B
    Presse Med; 2012 Oct; 41(10):986-95. PubMed ID: 22884126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.